Francisco Beça1,2,3, Rosário André4,5, Duarte Saraiva Martins6, Tiago Bilhim7, Diana Martins2, Fernando Schmitt2,8,9
1 - Department of Medical Oncology, Dana-Farber Cancer Institute/Harvard Medical School, Boston, Massachusetts, USA
2 - IPATIMUP—Institute of Molecular Pathology and Immunology of the University of Porto, Porto, Portugal
3 - Faculty of Medicine, Department of Pathology and Oncology, University of Porto, Porto, Portugal
